↓ Skip to main content

Cost-effectiveness of Maintenance Capecitabine and Bevacizumab for Metastatic Colorectal Cancer

Overview of attention for article published in JAMA Oncology, February 2019
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

news
1 news outlet
policy
2 policy sources
twitter
31 X users
facebook
1 Facebook page
googleplus
1 Google+ user

Readers on

mendeley
85 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Cost-effectiveness of Maintenance Capecitabine and Bevacizumab for Metastatic Colorectal Cancer
Published in
JAMA Oncology, February 2019
DOI 10.1001/jamaoncol.2018.5070
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 31 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 85 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 85 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Student > Master 13 15%
Student > Bachelor 12 14%
Student > Ph. D. Student 7 8%
Researcher 7 8%
Other 6 7%
Other 8 9%
Unknown 32 38%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 21 25%
Pharmacology, Toxicology and Pharmaceutical Science 11 13%
Nursing and Health Professions 5 6%
Social Sciences 4 5%
Economics, Econometrics and Finance 2 2%
Other 10 12%
Unknown 32 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 32. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 June 2023.
All research outputs
#1,402,261
of 29,039,190 outputs
Outputs from JAMA Oncology
#1,857
of 3,701 outputs
Outputs of similar age
#30,761
of 467,999 outputs
Outputs of similar age from JAMA Oncology
#49
of 93 outputs
Altmetric has tracked 29,039,190 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,701 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 83.3. This one is in the 49th percentile – i.e., 49% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 467,999 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 93 others from the same source and published within six weeks on either side of this one. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.